Oncology News & Articles

1 Phase II study of bevacizumab and erlotinib in the treatment of advanced hepatocellular carcinoma patients with sorafenib-refractory disease Full Text Investigational New Drugs, March 14, 2012    Clinical Article

2 Efficacy and Safety of Everolimus in Elderly Patients With Metastatic Renal Cell Carcinoma: An Exploratory Analysis of the Outcomes of Elderly Patients in the RECORD-1 Trial Full Text European Urology, March 14, 2012    Clinical Article

3 Phase I trial of dasatinib and ixabepilone in patients with solid tumors Full Text Investigational New Drugs, March 14, 2012    Clinical Article

4 Effects of a pre-visit educational website on information recall and needs fulfilment in breast cancer genetic counselling, a randomized controlled trial Full Text Breast Cancer Research, March 14, 2012

5 Breastfeeding and the Risk of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers Full Text Breast Cancer Research, March 14, 2012

6 Physical and psychosocial recovery in the year after primary treatment of breast cancer Full Text Journal of Clinical Oncology, March 12, 2012 Original Publication Date: February 11, 2011    Clinical Article

7 Phase I Trial of Weekly and Twice-Weekly Bortezomib with Rituximab, Cyclophosphamide, and Prednisone in Relapsed or Refractory non-Hodgkin Lymphoma Full Text Clinical Cancer Research, March 12, 2012 Original Publication Date: March 14, 2011    Clinical Article

8 A gene expression signature from human breast cancer cells with acquired hormone independence identifies MYC as a mediator of antiestrogen resistance Full Text Clinical Cancer Research, March 12, 2012 Original Publication Date: March 14, 2011

9 Combined promoter methylation analysis of CADM1 and MAL: An objective triage tool for high-risk human papillomavirus DNA positive women Full Text Clinical Cancer Research, March 12, 2012 Original Publication Date: March 11, 2011

10 An Empirical Evaluation of Guidelines on Prostate-specific Antigen Velocity in Prostate Cancer Detection Full Text Journal of the National Cancer Institute, March 12, 2012 Original Publication Date: March 14, 2011    Clinical Guideline

11 A high-throughput proteomic approach provides distinct signatures for thyroid cancer behavior Full Text Clinical Cancer Research, March 12, 2012 Original Publication Date: March 11, 2011

12 Poor adherence is the main reason for loss of CCyR and imatinib failure for CML patients on long term therapy Full Text Blood, March 12, 2012 Original Publication Date: March 11, 2011    Clinical Article

13 Pretreatment EGFR T790M Mutation and BRCA1 mRNA Expression in Erlotinib-Treated Advanced Non-Small-Cell Lung Cancer Patients with EGFR Mutations Full Text Clinical Cancer Research, March 12, 2012 Original Publication Date: March 11, 2011

14 Phase I, pharmacokinetic and pharmacodynamic study of SJG-136, a novel DNA sequence selective minor groove cross-linking agent, in advanced solid tumors Full Text Clinical Cancer Research, March 12, 2012 Original Publication Date: March 14, 2011

15 The replication rate of human hematopoietic stem cells in vivo Full Text Blood, March 12, 2012 Original Publication Date: March 11, 2011

16 Inhibition of prostate cancer osteoblastic progression with VEGF121/rGel, a single agent targeting osteoblasts, osteoclasts, and tumor neovasculature Full Text Clinical Cancer Research, March 12, 2012 Original Publication Date: March 11, 2011

17 Human Monoclonal Antibodies to Sialyl-Lewisa (CA19.9) with Potent CDC, ADCC, and Antitumor Activity Full Text Clinical Cancer Research, March 12, 2012 Original Publication Date: March 11, 2011

18 Yes-associated Protein 1 Exhibits Oncogenic Property in Gastric Cancer and Its Nuclear Accumulation Associates With Poor Prognosis Full Text Clinical Cancer Research, March 12, 2012 Original Publication Date: March 11, 2011

19 Modulators of Arginine Metabolism Do Not Impact on Peripheral T-Cell Tolerance and Disease Progression in a Model of Spontaneous Prostate Cancer Full Text Clinical Cancer Research, March 12, 2012 Original Publication Date: March 11, 2011

20 C/EBP alpha and C/EBP alpha oncoproteins regulate nfkb1 and displace histone deacetylases from NF-kB p50 homodimers to induce NF-kB target genes Full Text Blood, March 12, 2012 Original Publication Date: March 11, 2011

Stereotactic ablative radiotherapy for stage I NSCLC: Recent advances and controversies Journal of Thoracic Disease, 08/05/2011

1 Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP Protocol B-24 Journal of Clinical Oncology, April 9, 2012

2 The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal Journal of Gastrointestinal Oncology, April 16, 2012    Free full text

3 Preoperative chemotherapy plus trastuzumab, lapatinib, or both in human epidermal growth factor receptor 2-positive operable breast cancer: Results of the randomized phase III CHER-LB study Journal of Clinical Oncology, April 12, 2012

4 Ovarian function suppression and fulvestrant as endocrine therapy in premenopausal women with metastatic breast cancer European Journal of Cancer, April 2, 2012

5 Metformin use is associated with better survival of diabetic patients with pancreatic cancer Clinical Cancer Research, April 4, 2012

6 Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study The Lancet, April 24, 2012

7 Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials The Lancet Oncology - Online First, March 22, 2012

8 Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data Journal of Clinical Oncology, April 5, 2012

9 Rapid-onset hypogonadism secondary to crizotinib use in men with metastatic nonsmall cell lung cancer Cancer, April 6, 2012

10 Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial The Lancet Oncology - Online First, March 28, 2012

11 Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial The Lancet - Early Online Publication, April 5, 2012

12 The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus International Journal of Cancer, April 26, 2012

13 Infectious complications of chemotherapy in clinically aggressive mature B and T cell lymphomas European Journal of Internal Medicine , April 3, 2012

14 Carboplatin and paclitaxel with vs without bevacizumab in older patients with advanced non-small cell lung cancer JAMA, April 19, 2012

15 Association between tamoxifen treatment and diabetes Cancer, April 16, 2012

16 The utility of serum CA-125 in predicting extra-uterine disease in apparent early-stage endometrial cancer International Journal of Cancer, April 23, 2012

17 Pneumonitis associated with mTOR inhibitors therapy in patients with metastatic renal cell carcinoma: Incidence, radiographic findings and correlation with clinical outcome European Journal of Cancer, April 11, 2012

18 Digoxin use and the risk of cancers of the corpus uteri, ovary and cervix International Journal of Cancer, April 18, 2012

19 Gefitinib versus placebo as maintenance therapy in patients with locally advanced or metastatic non-small-cell lung cancer (INFORM; C-TONG 0804): a multicentre, double-blind randomised phase 3 trial The Lancet Oncology - Online First, April 20, 2012

20 Multicenter randomized phase II clinical trial comparing neoadjuvant oxaliplatin, capecitabine, and preoperative radiotherapy with or without cetuximab followed by total mesorectal excision in patients with high-risk rectal cancer (EXPERT-C) Journal of Clinical Oncology, April 9, 2012